Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02714062 · ClinicalTrials.gov registry record · Phase 4

A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents

A Phase 4 study of Pediatric Obesity and Childhood Obesity, sponsored by VIVUS.

Completed
Registry status
Phase 4
Development phase
42
Enrollment target
4
Study locations

NCT02714062 is a Phase 4 study of Pediatric Obesity and Childhood Obesity that has completed, run by VIVUS. The registered enrollment target is 42 participants, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (82% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02714062, a Phase 4 study of Pediatric Obesity and Childhood Obesity, has completed, sponsored by VIVUS.

COMPLETED
Registry status
Phase 4
Development phase
42 participants
Enrollment target
4
Study locations

Study Summary

The primary objective of this study is to describe the pharmacokinetic profiles of VI-0521 in obese adolescents.

Interventions

  • DRUG Placebo
  • DRUG VI-0521 Mid Dose
  • DRUG VI-0521 Top Dose

Study Locations (4)

Louisiana

  • Research Facility - Baton Rouge
  • Research Facility - Marrero

Ohio

  • Research Facility - Cincinnati

South Carolina

  • Research Facility - Charleston

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2016-03
Est. Completion 2016-11
Phase Phase 4

Sponsor

VIVUS

35 total trials

What the Registry Record Tells You About NCT02714062

The ClinicalTrials.gov registry entry for NCT02714062 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (82% lower). The listed sponsor is VIVUS, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pediatric Obesity appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02714062 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Louisiana, Ohio, South Carolina.

Frequently Asked Questions

What is clinical trial NCT02714062 about?

NCT02714062 is a clinical study titled "A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents". The primary objective of this study is to describe the pharmacokinetic profiles of VI-0521 in obese adolescents.

What is the current status of trial NCT02714062?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2016-03. Estimated completion is 2016-11.

What conditions does trial NCT02714062 study?

This clinical trial studies the following conditions: Pediatric Obesity, Childhood Obesity.

What interventions are being tested in trial NCT02714062?

The interventions under investigation include: Placebo (DRUG), VI-0521 Mid Dose (DRUG), VI-0521 Top Dose (DRUG).

Who is sponsoring clinical trial NCT02714062?

This trial is sponsored by VIVUS, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02714062 being conducted?

This trial has 4 study locations across Louisiana, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.